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Abstract Protein tyrosine phosphatases (PTPs) are key
regulators of different processes during development of the
central nervous system. However, expression patterns and
potential roles of PTPs in the developing superior colliculus
remain poorly investigated. In this study, a degenerate pri-
mer-based reverse transcription-polymerase chain reaction
(RT-PCR) approach was used to isolate seven different
intracellular PTPs and nine different receptor-type PTPs
(RPTPs) from embryonic E15 mouse superior colliculus.
Subsequently, the expression patterns of 11 PTPs (TC-PTP,
PTP1C, PTP1D, PTP-MEG2, PTP-PEST, RPTPJ, RPTPe,
RPTPRR, RPTPr, RPTPj and RPTPc) were further
analyzed in detail in superior colliculus from embryonic
E13 to postnatal P20 stages by quantitative real-time RT-
PCR, Western blotting and immunohistochemistry. Each of
the 11 PTPs exhibits distinct spatiotemporal regulation of
mRNAs and proteins in the developing superior colliculus
suggesting their versatile roles in genesis of neuronal and
glial cells and retinocollicular topographic mapping. At
E13, additional double-immunohistochemical analysis
revealed the expression of PTPs in collicular nestin-positive
neural progenitor cells and RC-2-immunoreactive radial
glia cells, indicating the potential functional importance of
PTPs in neurogenesis and gliogenesis.
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Introduction
The mouse retinocollicular system serves as an excellent
model to explore the molecular and cellular mechanisms of
axon growth and guidance as well as topographic map
formation. Retinal ganglion cells (RGCs) differentiate
within the retina at embryonic (E) day 11 (Cook 2003) and
extend their axons toward the optic ﬁssure. The ﬁrst retinal
axons travel out of the eye along the optic nerve and reach
the optic chiasm at E14. After crossing, the retinal axons
innervate their target, the superior colliculus, also known as
the optic tectum in non-mammalian vertebrates, between
E16 and postnatal (P) day 0 (Godement et al. 1984). Ret-
inal inputs to the superior colliculus are organized in a
precise topographic map, in which the temporal–nasal and
dorsal–ventral axes of the retina correspond to the anterior–
posterior and lateral–medial axes of the midbrain.
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of this topographic map has revealed gradients of tran-
scription factors and cell surface receptors in the retina
and tectum which guide its formation (Thanos and Mey
2001; O’Leary and McLaughlin 2005). Of interest here
are the protein tyrosine phosphatases (PTPs), a large
family of proteins that have been described to be impli-
cated in axon growth and guidance (Garrity et al. 1999;
Bixby 2000; Newsome et al. 2000; Stoker 2001) in dif-
ferent species. In RGC axons of Xenopus and chicken,
RPTP-LAR, RPTPd, RPTPl and RPTPr promote retinal
neurite outgrowth (Burden-Gulley and Brady-Kalnay
1999; Ledig et al. 1999; Johnson et al. 2001), growth
cone steering (Burden-Gulley et al. 2002) and targeting of
retinal axons within the optic tectum (Rashid-Doubell
et al. 2002). However, less is known regarding the
potential role of PTPs in the development of the mam-
malian superior colliculus.
In order to identify PTPs that might contribute to
signaling in the superior collicular development a
degenerate primer-based reverse transcription polymerase
chain reaction (PCR) approach was used to isolate cDNAs
encoding PTPs from embryonic (E15) mouse superior
colliculus. At this stage, neuronal and radial glial cells are
generated (Gotz and Huttner 2005) as well as retinal
ganglion axons ﬁrst contact the superior colliculus. Using
this approach seven different intracellular, non-trans-
membrane PTPs and nine different receptor-type PTPs
(RPTPs) were identiﬁed. Subsequently, the expression
pattern of 11 PTPs (TC-PTP, PTP1D, PTP1C, PTP-
MEG2, PTP-PEST, RPTPJ, RPTPe, RPTPRR, RPTPj,
RPTPc and RPTPr) was analyzed in more detail in
embryonic (E13, E15, E18) and postnatal (P0, P4, P12,
and P20) superior colliculus by real-time RT-PCR, Wes-
tern Blotting and immunohistochemistry. With ongoing
maturation, all 11 PTPs displayed a distinct spatiotem-
poral regulation of mRNAs and proteins in the pre- and
postnatal superior colliculus correlating with different
processes such as proliferation, differentiation, axonal
innervation and arborisation.
Methods
Animals
Adult NMRI mice were obtained from Charles River
Laboratories (Sulzfeld, Germany) and mated over night.
Females were checked for the presence of a vaginal plug,
which corresponds to the gestational day 0.5 (E0.5). For all
analyses, embryonic (E13, E15, E18) and postnatal (P0, P4,
P12, P16, P20) stages were determined according to the
staging criteria of Theiler (Bard et al. 1998).
RNA isolation and cDNA Synthesis
For RNA preparation, collicular tissue from each develop-
mental stage was isolated, pooled, frozen in liquid nitrogen
and stored at –70C until RNA extraction. Total RNA was
extracted according to the manufacturer’s instructions
(RNeasyMiniorMidikit,Qiagen,Hilden,Germany).Usinga
cDNA-synthesis kit (Fermentas GmbH, St. Leon-Rot, Ger-
many) 1 lg of total RNA was used for reverse transcription.
PCR ampliﬁcation of PTP sequences using degenerate
primers
To produce PCR-generated DNA-fragments corresponding
to PTP sequences in the conserved catalytic domain,
cDNAs were reversely transcribed from E15 superior col-
liculus and were used as a template for the ampliﬁcation
with Taq polymerase (Eppendorf, Germany). Degenerate
primers corresponding to amino acid sequences DFWQ(R/
K/E/G)MI(M/V)WD(E/Q/H) (upstream) and HCSAGI(V/
M)G (downstream) were synthesized by Invitrogen
(Carlsbad, CA, USA). Low stringency PCR-reaction con-
ditions were as follows: 5 min 94C, followed by 36 cycles
of 1 min at 94C, 1 min at 50C and 1 min at 72C. The
reaction products were run on 1.5% agarose gels, isolated,
ligated into pCRII-TOPO Plasmids (Invitrogen) and used
to transform competent E. coli TOP10 cells (Invitrogen,
Carlsbad, CA, USA). Clones that contained inserts were
sequenced using automated DNA sequencing (Department
of Molecular Neurobiochemistry, Ruhr-University-
Bochum). Obtained PCR fragment sequences were com-
pared to sequences covered in the NCBI databases.
Quantitative real-time RT-PCR
Real-time-PCR using Syber Green I (Eurogentec) was
performed on an Opticon-Cycler (MJ Research). Primer
sequences of both housekeeping genes b-actin and cyclo-
philin and of the identiﬁed ﬁve intracellular PTPs and six
RPTPs were designed (Horvat-Brocker et al. 2008). Their
sequences, expected amplicon sizes and accession numbers
are listed in Supplemental Table 1.
Primer concentration was optimized to a ﬁnal concen-
tration of 0.6 lM and combined with 20 ng RNA per well.
TotalthreereactionspersampleRNA(triplets)weresetwith
a ﬁnal volume of 20 ll per single reaction. Real-time PCR
was performed as described previously (Ray et al. 2005;
Horvat-Brocker et al. 2008). Brieﬂy, each RT-PCR was
performed from a pool of tissues originating from 15 dif-
ferentanimalspereachdevelopmentalstage.TheaverageCt
values of three independent experiments (triplicates) were
usedtocalculatetheratiosforintracellularPTPsasdescribed
before (Pfafﬂ et al. 2002). In order to obtain ampliﬁcation
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curves by a twofold dilution series with template amounts
ranging from 8 to 0.125 ng DNA per well. The efﬁciency of
the PCR reaction was calculated for each primer pair
accordingtotheequationE = 10
(-1/slope)(Pfafﬂetal.2002).
The relative expression (R) of PTPs was calculated based on
real-time PCR efﬁciency (E) and the threshold cycle (Ct)
deviation of PTP at each developmental stage versus a
control(embryonicstage13,E13)accordingtothefollowing
equation: R = (Etarget)
DCt target(MEAN control - MEAN sample)/
(Ereference)
DCt reference (MEAN control - MEAN sample). The Ct
values for the reference genes (in our case b-actin and cy-
clophilin) were needed to take into account different mRNA
levels of the sample. For statistical evaluation of Ct varia-
tionsandcalculatedrelativeexpressionvariations,datawere
analyzed for signiﬁcant differences by a pair wise ﬁxed
reallocation and randomization test, as described before
(Pfafﬂ et al. 2002).
Antibodies
The following primary antibodies were used for Western
blot analyses and immunohistochemical stainings: rabbit
anti-TC-PTP (Lammers et al. 1993), mouse anti-PTP1C
(Santa Cruz Biotechnology, Santa Cruz, United States),
rabbit anti-PTP1D (Stein-Gerlach et al. 1995; Tomic et al.
1995), rabbit anti-PTP-MEG2 (Sugen, Redwoodcity, CA,
USA), rabbit anti-PTP-PEST (Eurogentec, Ko ¨ln,
Germany), rabbit anti-RPTPJ (Jallal et al. 1997) rabbit anti-
RPTPj (Fuchs et al. 1996; Anders et al. 2006), rabbit anti-
RPTPc (Horvat-Brocker et al. 2008), rabbit anti-RPTPe
(Moller et al. 1995), rabbit anti-RPTPRR (Horvat-Brocker
et al. 2008), rabbit anti-RPTPr (Aicher et al. 1997), mouse
anti-b-actin (Sigma, St. Louis, MO, USA), mouse anti-
nestin (Chemicon, Temecula, CA, USA) and mouse anti-
RC2 (Developmental Studies Hybridoma Bank, University
of Iowa, Iowa City, IA, USA). The secondary antibodies
used for Western blot analyses and immunohistochemical
stainings were as follows: goat anti-mouse-CY3-coupled,
goat anti-mouse-CY2-coupled, goat anti-rabbit-CY3-cou-
pled, goat anti-rabbit-HRP-coupled and goat anti-mouse-
HRP-coupled antibodies (all from Dianova, Hamburg,
Germany).
Western blotting
For Western blotting, mouse collicular tissues from each
developmental stage (E13, E15, E18, P0, P4, P12, P16 and
P20) were isolated, pooled and immediately homogenized
in ice-cold lysis buffer (50 mM HEPES, pH 7.5, 150 mM
NaCl, 1.5 mM MgCl2, 5 mM EGTA, 10% v/v glycerin, 1%
v/v Triton X-100, 0.1 mM Na3VO4,1 0lg/ml aprotinin,
10 lg/ml leupeptine, 1 mM phenylmethylsulfonyl ﬂuo-
ride). Lysates were clariﬁed by centrifugation at 12,0009g
for 20 min at 4C. The protein concentration was deter-
mined using a BCA Protein Assay Kit (Pierce, Rockford,
USA). 20 lg of each protein lysate was separated on
4–10% SDS-polyacrylamide gels (Roth, Karlsruhe,
Germany). Immunoblotting and immunodetection were
performed as described previously (Horvat-Brocker et al.
2008) using the following primary PTP-antibodies: rabbit
anti-TC-PTP (1:2,000), mouse anti-PTP1C (1:2,000), rab-
bit anti-PTP1D (1:2,000), rabbit anti-PTP-MEG2
(1:1,000), rabbit anti-PTP-PEST (1:2,000), rabbit anti-
RPTPJ (1:1,000), rabbit anti-RPTPj (1:1,000), rabbit anti-
RPTPc (1:1,000), rabbit anti-RPTPe (1:1,000), rabbit
anti-RPTPRR (1:1,000) and rabbit anti-RPTPr (1:1,000).
Immunoreactivities were detected using goat anti-rabbit-
HRP-coupled or anti-mouse-HRP-coupled secondary anti-
bodies (1:12000). Protein bands were detected using
enhanced chemiluminescence ECL (Roth). After stripping
with Restore Western blot Stripping Buffer (Pierce) all
blots were reprobed using mouse anti-b-actin antibody
(Sigma, 1:5,000), which indicates nearby equal amounts of
proteins per each analysed developmental stage. Protein
levels were quantiﬁed by using image J analysis software
Table 1 Cloning and identiﬁcation of intracellular and receptor-type
protein tyrosine phosphatases (PTPs) from embryonic E15 mouse
superior colliculus using a degenerate primer-based RT-PCR
approach
PTPs No. of PTP
clones = 310 (%)
RPTPr 158 (51)
RPTP-LAR 62 (20)
TC-PTP 23 (7.4)
PTP1B 17 (5.5)
RPTPJ 12 (4)
RPTPRR 9 (3)
RPTPe 9 (3)
RPTPd 5 (1.6)
RPTPa 3 (0.9)
PTP-MEG2 3 (0.9)
PTP36 2 (0.6)
PTP1C 2 (0.6)
PTP1D 2 (0.6)
RPTPj 1 (0.3)
RPTPc 1 (0.3)
PTP-PEST 1 (0.3)
The reampliﬁed intracellular PTPs and receptor-type protein tyrosine
phosphatases (RPTPs) cloned by RT-PCR were ranked by the relative
abundance of the PCR products. The seven different intracellular
PTPs (TC-PTP, PTP1B, PTP-MEG2, PTP36, PTP1C, PTP1D and
PTP-PEST) recovered in the E15 mouse superior colliculus screen
represented 50 (16%) from a total of 310 clones. The nine different
RPTPs (RPTPr, RPTP-LAR, RPTPJ, RPTPRR, RPTPe, RPTPd,
RPTPa, RPTPj and RPTPb/f) were represented by 260 clones (84%)
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123(Version 1.41, National Institutes of Health, USA). The
relative expression values (normalized protein levels) of
PTP-proteins were calculated based on b-actin signals and
the expression level at E13 (set to 0).
Immunohistochemistry and confocal laser-scanning
microscopy
For immunohistochemistry, whole embryo heads or post-
natal brains were ﬁxed in 4% w/v paraformaldehyde (PFA)
in phosphate buffered saline (PBS) at 4C and cryopro-
tected in 30% w/v sucrose/PBS. Tissue was sectioned in
sagittal planes at 16 lm using a cryostat (Leica, Bensheim,
Germany) and collected onto Superfrost plus object slides
(Menzel-Glaeser, Braunschweig, Germany). Slides were
stored at -80C until required. Immunohistochemical
labeling was carried out as described previously (Horvat-
Brocker et al. 2008) by using the following primary anti-
bodies: PTP-antibodies (all 1:500), anti-nestin (1:300) and
anti-RC-2 (1:10). Adequate secondary antibodies were as
follows: subclass-speciﬁc CY3-coupled anti-rabbit and
anti-mouse antibodies (all 1:300, Dianova, Hamburg, Ger-
many). Control slides without primary antibodies were
immunonegative. All immunoﬂuorescence stainings were
analyzed by using a confocal laser-scanning microscope
LSM 510 META (Zeiss, Go ¨ttingen, Germany). Laser lines
and emission ﬁlters were optimized with the Zeiss LSM
Image Browser software. Brightness and contrast of the
images were adjusted using Adobe Photoshop software
(version 8.0.1; Adobe Systems, Mountain View, CA, USA).
Results
Identiﬁcation of PTPs expressed in the mouse superior
colliculus at embryonic stage 15 (E15) by degenerate
primer RT-PCR
In order to identify PTPs that might contribute to the sig-
naling in the embryonic (E15) mouse superior colliculus, a
degenerate primer-based RT-PCR approach was used. At
E15, retinal ganglion axons start to innervate the superior
colliculus (Edwards et al. 1986; Herrera et al. 2003) and
intensive genesis processes (differentiation, proliferation,
migration) of neuronal and radial glial cells occur (Altman
and Bayer 1981; Edwards et al. 1986; Galileo et al. 1990).
The primers used in this study were synthesized based on
the catalytic domains of PTPs (DFWQ(R/K/E/G)MI(M/
V)WD(E/Q/H) (upstream) and HCSAGIG (downstream)).
Single PCR products were isolated and ligated into a
pCRII-TOPO Vector (Invitrogen). Three hundred and ten
clones were sequenced, and fragments containing PTP-like
domains were identiﬁed. These 310 cDNA-fragments
encoded 16 different PTPs in the mouse superior colliculus
at E15. Novel PTP sequences were not found. From a total
of 310 clones 50 clones (16%) coded for seven different
intracellular PTPs, whereas 260 clones (84%) coded for
nine different RPTPs. The relative abundance of different
intracellular PTPs and RPTPs among the RT-PCR-gener-
ated cDNAs is shown in Table 1. The four most abundant
cDNAs were RPTPr (158 clones), RPTP-LAR (62 clones),
TC-PTP (23 clones) and PTP1B (17 clones). The ﬁfth most
abundant cDNAs (12 clones) encoded RPTPJ. Nine cDNAs
encoded RPTPRR and RPTPe, while ﬁve cDNAs encoded
RPTPd. RPTPa and PTP-MEG2 were represented by three
clones each. For the intracellular protein tyrosine phos-
phatases PTP36, PTP1C and PTP1D each two clones were
identiﬁed. RPTPj, RPTPc and PTP-PEST were repre-
sented by only one single clone each.
Quantitative real-time RT-PCR and Western blotting
revealed differential regulation of PTP mRNAs
and proteins during development of mouse
superior colliculus
Since antibodies for all PTPs, which were identiﬁed with
degenerate primers in the E15 mouse superior colliculus,
were not available in this study, we focused on the 11 PTPs:
ﬁve intracellular PTPs (TC-PTP, PTP1C, PTP1D, PTP-
MEG2 and PTP-PEST) and six receptor-type PTPs (RPTPJ,
RPTPj, RPTPc, RPTPe, RPTPRR and RPTPr). To study
the role of these PTPs in the developing mouse superior
colliculus in detail, the regulation of the corresponding
mRNAs and proteins was ﬁrst investigated by quantitative
real-time RT-PCR and Western blotting at different devel-
opmental time points (E13, E15, E18, P0, P4, P8, P12, P16
and P20). The embryonic and postnatal stages from E13 to
P12 cover different developmental processes including
genesis of neuronal and glial cells, formation of synapses
and retinocollicular topographic mapping. Sequences of
primer pairs used in real-time RT-PCR experiments are
shown in Table 1 (Supplemental data).
The results of the quantitative real-time RT-PCRs
revealed equal amounts of mRNAs (Ct values = mean
threshold cycle) for the reference genes ß-actin and cyclo-
philin during collicular development (Supplemental data,
Table 2). At E13, the Ct values for the investigated PTPs
varied between 22 and 29, indicating different expression
levels of the PTPs at this early developmental stage (Sup-
plemental data, Table 2). With ongoing development of the
superior colliculus, the PTPs showed differential mRNA
patterns when compared to the expression level at E13
(set to 0) (Fig. 1a, b, Supplemental data, Table 2).
In comparison to E13, the expression of TC-PTP mRNA
decreased slightly during collicular development and
reachedasigniﬁcant(P\0.05)3(2
1.5)-folddownregulation
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123atP20 (Fig. 1a).InWesternBlotanalysis, TC-PTP antibody
recognized three protein bands at 45-, 48- and *50 kDa
(Fig. 2a). The 48 and 45 kDa bands correspond to the pre-
viously described two TC-PTP human isoforms (Tiganis
et al. 1998, 1999; Lam et al. 2001). The 50 kDa band cor-
responds probably to the intracellular protein tyrosine
phosphatase PTP1B, which shows more than 70% homol-
ogy to TC-PTP (Ibarra-Sanchez et al. 2000; Bourdeau et al.
2005). During development of the superior colliculus only
the 48 kDa TC-PTP isoform revealed almost the same
regulation pattern as TC-PTP mRNA, whereas the 45 kDa
isoform was uniformly expressed. Strong signals of the
50 kDa protein, corresponding probably to PTP1B, were
detected at E13 and E15 before dropping between E18 and
P16. At P20 a faint 50 kDa band was detected. However, it
has to be mentioned that primer pairs for TC-PTP ampliﬁ-
cation in real-time RT-PCR experiments did not amplify
PTP1B.
When compared with E13, the quantiﬁcation of PTP1C-
mRNA using real-time RT-PCR revealed a slight
downregulation at E15 (P\0.05) and E18 (Fig. 1a). At P0
the PTP1C mRNA expression returned to the level found at
E13. From P4 to P20, a slight upregulation of the gene was
observed (statistically not signiﬁcant). A similar expression
pattern was found at protein level, as revealed in the
immunoblot with speciﬁc anti-PTP1C antibody, which
recognized a single protein band at 67 kDa (Fig. 2b). This
band represents the full PTP1C protein as calculated from
the amino acid sequence.
The quantiﬁcation of PTP1D mRNA using real-time
RT-PCR revealed a 2(2
1)-4(2
2)-fold decrease in the
expression at the late embryonic stage E18 (P\0.001) and
the early postnatal stages P0 and P4 (P\0.01) when
compared to E13 (Fig. 1a). From P12 to P20, PTP1D
mRNA expression returned to the level found at E13.
Western Blot analysis revealed a similar expression pattern
(Fig. 2c). Using a speciﬁc PTP1D-antibody, a single
68 kDa band corresponding to the predicted molecular
weight of PTP1D was detected. A large amount of 68 kDa
protein was found at E13 before dropping between E15 and
P8. The signal intensity of 68 kDa protein increased in the
later postnatal stages (from P12 to P20).
The MEG2 mRNA and protein revealed constant
expression levels from E13 to P20 (Fig. 1a). In Western
Blot analysis, a speciﬁc PTP-MEG2 antibody recognized a
single protein band at 67 kDa (Fig. 2d), corresponding to
the predicted size.
In contrast to other intracellular PTPs, the PTP-PEST
mRNA expression was characterized through a continuous
2(2
1)-5(2
2.5)-fold decrease in superior colliculus develop-
ment (P\0.05 at E15, P4 and P12; P\0.001 at E18, P0
and P20, Fig. 1a). Note that the regulation of the PTP-
PEST protein, which was detected at *120 kDa using
Western blot analyses (Fig. 2e), correlates with the mRNA
expression as detected by quantitative real-time RT-PCR.
The predicted molecular weight of the murine PTP-PEST
is 86 kDa. As revealed by other groups (Davidson et al.
1997; Sirois et al. 2006; Halle et al. 2007) and as shown by
our analyses, PTP-PEST migrates in the range of 120 kDa.
When compared with E13, the mRNA regulation of the
receptor protein tyrosine phosphatase RPTPJ was charac-
terized through a 2(2
1)-4(2
2)-fold increase in the expression
from late embryonic stage E18 until P20 (at E18 and P0,
P\0.05; at P4, P12 and P20, P\0.01) (Fig. 1b). Nearby
thesameexpressionpatternwasfoundattheproteinlevel,as
revealed in the immunoblot with speciﬁc anti-RPTPJ anti-
body,whichrecognizeda159 kDaband(Fig. 3a).Although
the calculated molecular weight of RPTPJ is 134 kDa
(Kuramochi et al. 1996), our data indicate that during col-
licular development RPTPJ might be glycosylated.
The quantiﬁcation of RPTPj mRNA using real-time
RT-PCR revealed a 2(2
1)- to 4(2
2)-fold increase of the
expression level from E15 to P20 (P\0.05) in comparison
with E13 (Fig. 1b). Western blot analysis using speciﬁc
anti-RPTPj antibody (Fig. 3b) resulted in the detection of
four bands of 164, 115, 105 and 91 kDa. The 164 kDa
band represents the full RPTPj protein (Jiang et al. 1993),
while the 115-, 105- and 91 kDa bands correspond to the
proteolytic cleavage products of RPTPj (Anders et al.
2006). Weak signals of the full RPTPj protein (164 kDa)
were detected at E13 and E15 before being gradually
upregulated between E18 and P20. At E13, the 115-, 105-
and 91 kDa proteins were weakly expressed. A strong
upregulation of the 115 kDa protein was detected between
E15 and P8 prior to its gradual downregulation between
P12 and P20. The 105 kDa protein band was weakly but
nearby constantly present during collicular development. In
contrast, the 91 kDa protein was prominently detectable at
E15 and E18 and remained constantly present during
postnatal collicular development until P20. Taken together,
only the complete RPTPj protein (164 kDa) and the
91 kDa protein revealed the same regulation pattern as
RPTPj mRNA.
When compared with E13, the RPTPc mRNA revealed a
signiﬁcant increase 2(2
1)-fold to 3(2
1.5) of the expression
level from E15 to P4 (P\0.05). At P20 the expression
returned to the level found at E13 (Fig. 1b). In Western blot
analysis, the anti-RPTPc antibody recognized ﬁve bands of
161, 120, 114, 110 and 80 kDa (Fig. 3c). The 161 kDa band
corresponds to the predicted size deduced from the amino
acid sequences (Barnea et al. 1993; Shintani and Marunaka
1996). The 120, 114, 110 and 80 kDa bands might represent
the cleaved products of RPTPc (van Niekerk and Poels
1999). The full RPTPc protein (161 kDa) showed the same
regulation pattern as RPTPc mRNA. The large amount of
120 kDa protein was ﬁrst detected in later postnatal stages
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123(from P12 onward). A constantly weak signal from E15
onward was detected for the 114 kDa band. The small
amount of the 110 kDa protein was detected between E15
and P0 before increasing between P4 and P20. The amount
of the 80 kDa protein was almost undetectable until E15
and started to increase from E18 to P20.
The quantiﬁcation of RPTPe mRNA revealed a 2(2
1)-
fold to 4(2
2) constant upregulation from E15 onward
(P\0.05) when compared with E13 (Fig. 1b). A similar
regulation pattern of RPTPe was detected at the protein
level (Fig. 3d). The RPTPe antibody (Moller et al. 1995)
recognized a 160 kDa band that became gradually upreg-
ulated with the maturation of the superior colliculus. The
observed 160 kDa band corresponds to the highly glycos-
ylated form of RPTPe, which has been reported in the
mouse brain (Elson and Leder 1995).
Since several transmembrane and cytoplasmatic iso-
forms of the RPTPRR gene are known (Augustine et al.
2000a; Chirivi et al. 2004), primer pairs which span the
sequence between the extracellular and intracellular part of
the transmembrane RPTPBr7 isoform were used in the
quantitative real-time-PCR (Horvat-Brocker et al. 2008).
When compared with E13, a signiﬁcant 2-(2
1)-fold
upregulation of RPTPRR/RPTPBr7 mRNA was found at
P0 and P4 (P\0.05), while in other embryonic and
postnatal stages the expression level was almost the same
as at E13 (Fig. 1b). The anti-RPTPRR antibody, which was
raised against the intracellular domain (Horvat-Brocker
et al. 2008), recognized in Western blot four bands: 155-,
74-, 51- and 47 kDa (Fig. 3e). The 74-, 51- and 47 kDa
proteins correspond to the receptor like-RPTPRR isoforms
previously identiﬁed as RPTPBr7, RPTPPBSd (?) and
RPTPPBSd (-) (Ogata et al. 1995; Sharma and Lombroso
1995; Augustine et al. 2000b), which are the products of
alternative splicing of the RPTPRR gene (Augustine et al.
2000b; Chirivi et al. 2004). The 155 kDa band might
represent a glycosylated form of one of the receptor-like
isoforms. The strong signals of the 155 kDa protein, which
was detected in all embryonic stages (from E13 to E18),
decreased sharply at the day of birth (P0) and remained
weakly expressed during the whole postnatal period. The
RPTPBr7 protein (74 kDa) was detected only from E13 to
E18, whereas no band could be detected from P0 onward.
During collicular development, the RPTPPBSd (-) protein
appeared slightly downregulated, whereas the RPTPPBSd
(?) isoform was ﬁrst identiﬁed at P4 and reached the
maximum level at late postnatal stages (P16 and P20).
In contrast to the other investigated RPTPs, the RPTPr
mRNA showed a slight but signiﬁcant 4-(2
2)- and 2-(2
1)-
fold downregulation at P12 (P\0.05) and P20 (P\0.05),
respectively (Fig. 1b). As shown in Fig. 3f, an antibody
against RPTPr (Aicher et al. 1997) recognized three pro-
teins of 97-, 80- and 72 kDa. These bands represent three
proteolytically processed products of RPTPr as described
before (Aicher et al. 1997). The 97- and 80 kDa bands
were almost undetectable in the embryonic (E13 to E18)
and early postnatal stages. In contrast, the 72 kDa protein
band was ﬁrstly detected at E13. Taken together, all three
proteins showed an overlapping and nearby constant pat-
tern of regulation.
Spatiotemporal expression pattern of PTPs
in the embryonic E13 and postnatal P20 mouse superior
colliculus as revealed by immunohistochemistry
To determine the spatial and temporal localization of
PTP1C, PTP1D, PTP-MEG2, PTP-PEST, RPTPJ, RPTPj,
RPTPc, RPTPe, RPTPRR and RPTPr during development
of the mouse superior colliculus, immunohistochemical
analyses were performed at the early embryonic stage E13
and the late postnatal stage P20 (Figs. 4a–d, 5a–f). Due to
the cross-reactivity of the anti-TC-PTP antibody, which
also recognized PTP1B protein (Fig. 2a), no immunhisto-
chemical analysis was performed for this PTP. For the
other PTPs, appropriate antibodies already used in Western
blot analyses (Figs. 2b–e, 3a–f) were applied to sagittal
sections of the mouse superior colliculus. The speciﬁcity of
the immunhistochemical signals was determined in control
experiments using species-speciﬁc secondary CY3-labeled
antibodies. In these control experiments, no signals were
detected (data not shown). With the exception of RPTPJ,
that displayed a decreasing anterior–posterior protein gra-
dient (insert, Fig. 5a), the examination of the superior
colliculus in both anteroposterior and dorsoventral orien-
tation revealed no signiﬁcant protein expression gradients
of the investigated PTPs (Figs. 4a–d, 5b–f).
At E13, immunolabeling using antibodies for the intra-
cellular PTPs PTP1C, PTP1D, PTP-MEG2 and PTP-PEST
revealed a more uniform distribution throughout the whole
embryonic superior colliculus. Nevertheless, prominent
immunoreactivities for PTP1C, PTP1D and PTP-PEST
were found in the outer dorsal edge of the intermediate
zone (IZ) of the superior colliculus (Fig. 4a, b and d). In
Fig. 1 Temporal regulation of intracellular and receptor-type PTP
(RPTP) mRNAs as revealed by quantitative real time RT-PCR in the
developing mouse superior colliculus. The relative gene regulation of
TC-PTP, PTP1C, PTP1D, PTP-MEG2, PTP-PEST, RPTPJ, RPTPj,
RPTPc, RPTPe, RPTPRR and RPTPr (R = here displayed as 2log)
was calculated based on real-time PCR efﬁciency (E) and the
threshold cycle (Ct) deviation of PTPs at each developmental stage
(E15, E18, P0, P4, P12 and P20) versus a control (embryonic stage
13, E13) according to the following equation: R = (Etarget)
DCt
target(MEAN control - MEAN sample)/(Ereference)
DCt reference (MEAN
control - MEAN sample). All values represent the relative expression
ratio of PTPs in relation to each house keeping gene (reference)
(b-actin and cyclophilin) and were normalized to the expression level
at E13 ( control, set to 0). *P\0.05; **P\0.01; ***P\0.001
b
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123Fig. 2 Temporal regulation of intracellular PTP proteins as revealed
by Western blot analysis in the developing mouse superior colliculus.
Protein lysates of superior colliculus tissues from E13, E15, E18, P0,
P4, P8, P12, P16 and P20 were separated by SDS-PAGE, and
immunoblotted with TC-PTP (a), PTP1C (b), PTP1D (c), PTP-MEG2
(d) and PTP-PEST (e) antibodies, respectively. Molecular weights of
intracellular PTP proteins are indicated on the right. All blots were
reprobed for b-actin to demonstrate the equal protein loading.
Changes in the relative protein expression (normalized protein level)
of each PTP protein are shown in the graphical representations. In the
case of PTP1C, PTP1D, PTP-MEG2 and PTP-PEST each PTP
antibody recognized only one band, which corresponded to the
predicted molecular weights of these PTPs. However, the TC-PTP
antibody recognized three protein bands at 45, 48 and *50 kDa
(Fig. 2a). The 48 kDa and 45 kDa bands correspond to the previously
described two TC-PTP human isoforms, whereas the 50 kDa band
corresponds most probably to the intracellular protein tyrosine
phosphatase PTP1B. Note that proteins of the investigated intracel-
lular PTPs are differentially regulated during superior collicular
development
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123addition, all intracellular PTPs displayed stronger immu-
noreactivities in the ventricular zone (VZ) (Fig. 4a–d). At
P20, PTP1C-, PTP1D- and PTP-MEG2-immunoreactive
cells were found dispersed throughout the stratum griseum
superﬁciale (SuG) and the stratum opticum (Op) of the
superior colliculus (Fig. 4a, b and c). In contrast, no PTP-
PEST immunoreactivity was detected at P20 (Fig. 4d).
Here, rabbit non-immune serum labels only the pial surface
non-speciﬁcally.
In comparison to the intracellular PTPs, the receptor-
type PTPs RPTPJ and RPTPj revealed unique immuno-
stainings at E13. The RPTPJ-antibody strongly labeled
cells in the ventricular zone (VZ) and subventricular zone
(SVZ) of the embryonic superior colliculus (Fig. 5a),
whereas the RPTPj epitope was located on radial processes
that span the whole tissue (Fig. 5b). The most prominent
RPTPc- (Fig. 5c), RPTPe- (Fig. 5d) and RPTPr-immu-
noreactivities (Fig. 5f) were found in the intermediate zone
(IZ) of the E13 superior colliculus. In comparison to the
other RPTPs, RPTPRR immunoreactivity was found uni-
formly distributed throughout the E13 superior colliculus
(Fig. 5e). At P20, single RPTPJ- (Fig. 5a), RPTPc-
(Fig. 5c) and RPTPr-immunoreactive cells (Fig. 5f)
seemed to be restricted to the stratum griseum superﬁciale
(SuG) and stratum opticum (Op), whereas immunoﬂuo-
rescence signals of RPTPj (Fig. 5b), RPTPe (Fig. 5d) and
RPTPRR (Fig. 5e) revealed a more dispersed staining
pattern within all visual layers of the P20 superior
colliculus.
Cell-type speciﬁc expression of PTPs in collicular
neural progenitors and radial glia cells at E13
Based on our observations of a prominent PTP expression
in the early embryonic superior colliculus at E13, a period
of intense neurogenesis and gliogenesis, we hypothesized
a possible involvement of PTP proteins in the regulation
of early collicular neural progenitors and radial glia cells.
To determine whether PTPs are expressed by these spe-
ciﬁc cell types, we performed double-immunohistochem-
istry on E13 superior colliculus slides using antibodies
against PTPs and two different markers of early neuronal
precursor cells, nestin, and a subtype of radial glia cells,
RC-2 (Figs. 6–9). Within the superior colliculus, both
nestin- and RC-2 antibodies strongly labeled radially
oriented processes, which span the whole tissue. The most
prominent immunoreactivities for nestin as well as for
RC-2 positive cells/processes were found in close asso-
ciation with the subventricular and ventricular zones. In
comparison to the observed nestin-immunoreactivity,
decreased label intensity from the subventricular/ven-
tricular zone (SVZ/VZ) to the intermediate zone (IZ) was
found for RC-2.
Double-immunoﬂuorescence analysis revealed that the
immunoreactivity for the intracellular PTPs PTP1D, PTP-
MEG2 and PTP-PEST colocalized partially with the pre-
cursor cell marker nestin (Fig. 6) and the radial glia cell
marker RC-2 (Fig. 8). The most prominent signals were
observed in the VZ and SVZ. PTP1C immunoreactivity,
which was found most prominently in the outer edge of the
intermediate zone and in single cells of the ventricular
zone, showed reduced co-localization with RC-2 positive
cells in the ventricular zone and did not co-localize with
minor labeled cells in the intermediate zone. Considering
the species of the nestin and PTP1C antibodies (both
mouse, IgG) it was not possible to determine the co-
localization of the PTP1C protein with nestin-positive
precursor cells. We speculate that the overlap should be
minor, if any. This interpretation is in accordance with the
PTP1C-immunoreactivity, which was mostly found in
more mature cells of the IZ.
In addition, no co-localization with nestin-positive pro-
genitor cells (Fig. 7) and RC-2 positive radial glia cells
(Fig. 9) was observed for the receptor-type PTP RPTPJ. In
contrast, the RPTPj epitope was strongly co-expressed by
nestin- and by RC-2-positive cells, as revealed by a nearby
completely overlapping expression pattern (Figs. 7, 9).
RPTPc, RPTPe, RPTPRR and RPTPr were partially
expressed in nestin- and RC-2- double-positive cells/pro-
cesses (Figs. 7, 9).
Discussion
Our study of the PTP family highlights the identiﬁcation
and differential expression pattern of eleven PTPs during
critical periods of mouse superior colliculus histogenesis.
Quantitative real-time PCR and Western blotting of TC-
PTP, PTP1C, PTP1D, PTP-MEG2, PTP-PEST, RPTPJ,
RPTPj, RPTPc, RPTPe, RPTPRR and RPTPr revealed
distinct temporal changes of gene and protein expression
during collicular development. Moreover, double-immu-
nohistochemical analysis demonstrated for the ﬁrst time
that the intracellular PTPs PTP1D, PTP-MEG2 and PTP-
PEST and the receptor-type PTPs RPTPj, RPTPc, RPTPe,
RPTPRR and RPTPr are co-expressed in a diverse pattern
by collicular neural progenitors and radial glia cells at E13.
In the light of these particular regulatory patterns and
drawing on reports relating to other systems, we propose
that the tyrosine phosphatases play an important regulatory
role for the neural stem/progenitor cells in the superior
colliculus.
Using a degenerate primer-based RT-PCR approach we
identiﬁed TC-PTP and PTP1B as the most abundant
intracellular PTPs. As reported by previous studies, TC-
PTP shares 71% amino-acid identity with PTP1B
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123(Bourdeau et al. 2005; Ibarra-Sanchez et al. 2000). Based
on the cross-reactivity of the TC-PTP antibody used in
Western blotting, PTP1B was identiﬁed as a 50 kDa pro-
tein band. PTP1B has been detected in RGCs where it may
function as positive modulator of nerve ﬁber outgrowth
(Pathre et al. 2001). Therefore, it is conceivable that
PTP1B could play a crucial role for the establishment of
topographic retino-collicular projections. Consistent with
this view, PTP1B protein exhibited the most prominent
expression at early stages (E13 and E15), when the ﬁrst
RGC ﬁbers begin to grow out and innervate the superior
colliculus. Different from the case of PTP1B, the expres-
sion of TC-PTP is described here for the ﬁrst time for the
murine CNS, where two alternatively spliced isoforms
were visualized by Western blot. The constitutively
expressed 48 kDa TC-PTP isoform was gradually
downregulated during development, whereas the 45 kDa
isoform remained constant. Previously, two alternatively
spliced variants have been described in the human: a
48 kDa form, which is localized to the endoplasmatic
reticulum by a hydrophobic C-terminus, and a 45 kDa form
which lacks the hydrophobic C-terminus and is located in
the nucleus (Tiganis et al. 1998, 1999; Lam et al. 2001).
Earlier investigations reported a regulatory involvement of
TC-PTP in EGF- and PDGF-signal transduction pathways
(Tiganis et al. 1997; Persson et al. 2004; Mattila et al.
2005), which are implicated in cell proliferation and cell
adhesion processes. Furthermore, TC-PTP has been
described as a negative regulator of colony-stimulating
factor 1 signaling and macrophage differentiation
(Simoncic et al. 2006). Consistent with these reports, our
data suggest different potential roles of TC-PTP during
collicular development, especially in early developmental
stages.
PTP1C mRNAs and proteins were weakly expressed
during the embryonic stages and at the day of birth, while a
strong expression was detected from P4 onward. In addi-
tion, immunohistochemistry revealed a prominent expres-
sion of PTP1C in the intermediate zone (IZ) of the superior
colliculus, which consists of more mature cells at E13.
Furthermore, PTP1C was detected in cells scattered
throughout the SuG and Op of the superior colliculus at
P20. As shown by Jena et al. (1997), PTP1C is associated
with synaptic vesicles and interacts directly with the
vesicular protein synaptophysin, which suggests an
involvement of PTP1C in synaptic transmission. Indeed,
the expression proﬁle of PTP1C in the superior colliculus
correlates well with synaptogenesis, which starts approxi-
mately at P1 (Lo and Mize 1999). Furthermore, synapto-
physin is up-regulated during neuronal development and
maturation (Becher et al. 1999a, b). In addition, previous
studies reported that PTP1C is involved in proliferation and
differentiation of astrocytes, microglia (Horvat et al. 2001;
Wishcamper et al. 2001) and oligodendrocytes (Massa
et al. 2004). These cell types are generated at late embry-
onic and early postnatal stages.
The peak amount of PTP1D mRNA and protein was
detected at E13 and at late postnatal stages. The strong
expression of PTP1D at E13, the sharp drop at late
embryonic and early postnatal stages and the subsequent
increased expression at late developmental stages are in
agreement with the assumption that PTP1D could adopt
different functions during the early and late development of
the superior colliculus. PTP1D may affect cell growth, cell
adhesion and cell motility either as a positive or a negative
regulator of distinct signal transduction pathways (Li et al.
1994; Matozaki et al. 1994; Noguchi et al. 1994; Miao
et al. 2000; Poliakov et al. 2004; Zhang et al. 2004). In
addition, PTP1D directly interacts with EphA2 and inﬂu-
ences directional cell migration. In this context, the impact
of the Eph family in patterning and establishing the topo-
graphic mapping within the visual system is well described
(Flanagan and Vanderhaeghen 1998; Feldheim et al. 2000,
2004). Furthermore, we could show that PTP1D is
expressed in RC-2 positive radial glia cells during early
collicular development, which could hint at a potential
functional role of this PTP in neuronal migration processes.
PTP-MEG2 mRNA and protein were continuously
expressed from E13 to P20, indicating its important role
during development as well as in the maintenance of a
Fig. 3 Temporal regulation of RPTP proteins as revealed by Western
blot analysis in the developing mouse superior colliculus. Protein
lysates of superior colliculus tissue from E13, E15, E18, P0, P4, P8,
P12, P16 and P20 were separated by SDS-PAGE and immunoblotted
with RPTPJ (a), RPTPj (b), RPTPc (c), RPTPe (d), RPTPRR (e) and
RPTPr (f) antibodies, respectively. Molecular weights of RPTP
proteins are indicated on the right. All blots were reprobed for b-actin
to demonstrate the equal protein loading. Changes in the relative
protein expression (normalized protein level) of each RPTP protein
are shown in the graphical representations. RPTPJ (a) and RPTPe (d)
proteins are detected with appropriate antibodies each as single bands
at 159 and 160 kDa, respectively. Immunoblots of RPTPj (b), RPTPc
(c) and RPTPr (f) reveal several bands, which correspond to the
integral proteins and their derived cleavage products. The anti-RPTPj
antibody detects four bands: 164 kDa (full protein) and its 115, 105
and 91 kDa cleavage products (b). The anti-RPTPc antibody recog-
nizes ﬁve bands (c): 161 kDa (full protein) and its 120, 114, 110 and
80 kDa cleavage products. As shown in (f), the antibody against
RPTPr recognizes only the cleavage products at 97, 80 and 72 kDa,
whereas the full protein RPTPr (168 kDa) could not be detected.
RPTPRR antibody detects three bands, which correspond to the
alternatively spliced receptor-like isoforms of the RPTPRR gene
(74 kDa RPTPBr7, 51 kDa PTPPBSd (?) and 47 kDa PTPPBSd
(-)). An additional 155 kDa band detected by anti-RPTPRR might
represent the glycosylated form of one of the receptor-like isoforms
(e). Note that the investigated RPTPs and their products (either
cleavage products or alternatively spliced isoforms) are differentially
regulated during collicular development, providing an evidence for
differential regulation at the level of posttranslational modiﬁcation
through proteolytic cleavage or alternative splicing
b
Exp Brain Res (2009) 199:279–297 289
123mature superior colliculus. A strong PTP-MEG2 immu-
noreactivity was detected throughout all layers of E13
superior colliculus, whereas at P20 the protein was
restricted to single cells of the SuG and Op. Interestingly,
PTP-MEG2 deﬁcient mice display several severe neuro-
developmental deﬁcits such as neural tube defects associ-
ated with craniofacial abnormalities, exencephaly,
encephalocoeles and meningomyelocoeles. In addition, the
brains of neonatal PTP-MEG2 null-mice are grossly
smaller in comparison to wild type animals (Wang et al.
2005). Extrapolating from the severe developmental
defects that were observed in the null-mice, PTP-MEG2
might be involved in a diversity of signal transduction
pathways that regulate neurulation processes. Consistent
Fig. 4 Spatiotemporal expression pattern of PTP1C (a), PTP1D (b),
PTP-MEG2 (c) and PTP-PEST (d) in the embryonic (E13) and
postnatal (P20) mouse superior colliculus. Sagittal sections through
the embryonic (E13) and late postnatal (P20) superior colliculus were
labeled with appropriate intracellular PTP antibodies. Dorsal and
posterior orientation is schematically presented. a–d At E13, immu-
noﬂuorescent staining using antibodies against PTP1C, PTP1D, PTP-
MEG2 and PTP-PEST reveals a more uniform distribution throughout
the whole superior colliculus. (b–d) The strongest signals for PTP1C,
PTP-1D and PTP-PEST were obtained in the outer dorsal edge of the
intermediate zone (IZ). a–d In addition, a prominent immunoreactiv-
ity for all intracellular PTPs was found in the ventricular zone (VZ)o f
the embryonic superior colliculus. a–c At P20, PTP1C-, PTP1D- and
PTP-MEG2-immunoreactivities were found in single cells scattered
throughout the stratum griseum superﬁciale (SuG) and the stratum
opticum (Op) of the superior colliculus. d In contrast, no immuno-
reactivity was found for PTP-PEST at P20. Here, rabbit non-immune
serum labels only the pial surface non-speciﬁcally. IZ intermediate
zone, VZ/SVZ ventricular zone/subventricular zone, ZO stratum
zonale, SuG stratum griseum superﬁciale, Op stratum opticum. Scale
bar 50 lm
Fig. 5 Spatiotemporal expression pattern of RPTPJ (a), RPTPj (b),
RPTPc (c), RPTPe (d), RPTPRR (e) and RPTPr (f) in the embryonic
(E13) and mature (P20) mouse superior colliculus. Sagittal sections
through the embryonic (E13) and late postnatal superior colliculus
(P20) were labeled with appropriate RPTP-antibodies. Dorsal and
posterior orientation is schematically presented. a At E13, a
polyclonal antibody against RPTPJ detects single immunoreactive
cells in the subventricular zone (SVZ) of the embryonic superior
colliculus. In addition we found RPTPJ expressing cells in a
decreasing anterior–posterior gradient (insert, Fig. 5a). Insert: lower
magniﬁcation of a RPTPj stained sagittal section of the E13 superior
colliculus (scale bar = 200 lm). In the P20 superior colliculus,
single cells, scattered throughout the stratum griseum superﬁciale
(SuG) and stratum opticum (SO), were labeled. b The RPTPj epitope
is located on radial processes in the embryonic superior colliculus,
whereas in the P20 superior colliculus a broad RPTPj-immunoreac-
tivity was found within all visual layers. (c, d and f) The strongest
RPTPc-, RPTPe- and RPTPr-immunoreactivities were found in the
dorsal part of the E13 superior colliculus (IZ intermediate zone). At
P20, RPTPc and RPTPr immunoreactive cells were restricted to the
stratum griseum superﬁciale (SuG) and stratum opticum (SO),
whereas RPTPe immunoreactivity displays a more dispersed distri-
bution pattern. e Immunolabeling using a polyclonal RPTPRR
antibody reveals a weak and uniform staining pattern in the
embryonic as well as in the P20 superior colliculus. IZ intermediate
zone, VZ/SVZ ventricular zone/subventricular zone, ZO stratum
zonale, SuG stratum griseum superﬁciale, Op stratum opticum. Scale
bar 50 lm
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123with this view, PTP-MEG2 controls the development and
growth of erythrocyte precursors cells (Xu et al. 2003). A
potential neuro-developmental role of PTP-MEG2 is sup-
ported by its expression in nestin-positive radial glia cells
and neuronal collicular progenitors. Therefore, we believe
that this PTP might act as a molecule which impacts on the
differentiation pathway of these specialized cell types.
In contrast to other intracellular PTPs, PTP-PEST
mRNA and protein levels were dramatically downregu-
lated from P0 onward. Immunohistochemical analysis
revealed a prominent expression of this PTP in early col-
licular progenitor- and radial glia cells, while it was absent
at P20. These ﬁndings suggest that PTP-PEST might be
involved in the regulation of early developmental pro-
cesses, such as cell proliferation, differentiation and
migration. Indeed, similar to PTP1D, PTP-PEST acts as a
negative regulator of cell migration processes (Davidson
et al. 1997; Garton et al. 1997; Shen et al. 1998; Garton and
Tonks 1999; Davidson and Veillette 2001).
Fig. 6 Co-localization of PTP1D, PTP-MEG2 and PTP-PEST pro-
teins in nestin-positive neural progenitor cells in the E13 mouse
superior colliculus. Sagittal sections through the embryonic E13
superior colliculus were double-labeled with antibodies against PTPs
and the neural progenitor marker nestin. Arrowheads indicate
examples of double-labeled cells. PTP1D, PTP-MEG2 and PTP-
PEST epitopes partially co-localize with nestin-positive neural
progenitor cells. Because the nestin- and PTP1C antibodies originated
from the same species (both mouse, IgG), it was not possible to
analyse the co-localization of the PTP1C protein with nestin-positive
precursor cells. Note that the antibodies directed at intracellular PTPs
label mainly nuclei/perikarya of collicular cells; both markers reveal
an incomplete overlapping expression pattern (merge). IZ intermedi-
ate zone, VZ/SVZ ventricular zone/subventricular zone. Scale bar
50 lm
Fig. 7 Co-localization of RPTPJ, RPTPj, RPTPc, RPTPe, RPTPRR
and RPTPr proteins in nestin-positive neural progenitor cells in the
E13 mouse superiors colliculus. Sagittal sections through the embry-
onic E13 superior colliculus were double-labeled with antibodies
against RPTPs and the neural progenitor marker nestin. Arrowheads
indicate examples of double-labeled cells. Note that RPTPc, RPTPe,
RPTPRR and RPTPr epitopes partially co-localize with nestin-
positive progenitors. In contrast, RPTPJ was not co-localized with
nestin-positive cells. Since nestin produces strictly radial staining
whereasRPTPJ,RPTPc,RPTPe,RPTPRRandRPTPrantibodieslabel
mainly nuclei/perikarya of collicular cells, both markers reveal a faint
overlapping expression pattern (merge). As shown for RC-2 immuno-
stainings, RPTPj immunoreactivity directly overlaps with nestin-
intermediate ﬁlament staining (merge). In comparison to the RC-2/
RPTPj overlap, the correspondence of nestin and RPTPj appears less
extensive. IZ intermediate zone, VZ/SVZ ventricular zone/subventric-
ular zone. Inserts: Higher magniﬁcation of immunopositive cells
(merge ﬁgures represent co-immunoreactive cells). Scale bar 50 lm
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RPTPj, RPTPc and RPTPe displayed a constant up-regu-
lation of mRNAs and proteins during collicular develop-
ment, suggesting an important role both in developmental
processes and in homeostasis of the mature superior
colliculus.
A strong expression of the RPTPJ-epitope was restricted
to single cells within the subventricular and ventricular
zones (SZV/VZ) of the E13 superior colliculus. These areas
contain predominantly immature proliferative and early
postmitotic cells. Interestingly, in C. elegans RPTPJ regu-
lates signaling of the EGF-receptor and enables Notch-
dependent determination and differentiation of certain cell
types (Berset et al. 2005); in the human and mouse, RPTPJ
exhibits tumor-suppressor activity (Keane et al. 1996;
Trapasso et al. 2000; Ruivenkamp et al. 2002). Thus, we
assume that the expression of RPTPJ in the embryonic
superior colliculus might be necessary to promote
neurogenic/gliogenic determination and differentiation of
speciﬁc collicular progenitors. In fact, we found no
co-localization of RPTPJ with early immature neural pro-
genitors or radial glia cells, which supports the notion of a
potential role in cell fate determination and speciﬁcation. In
addition, RPTPJ was expressed in a decreasing anterior-
posterior gradient-like pattern, which suggests that the
determination of speciﬁc cell types starts in the most ante-
rior part during superior colliculus development. This gra-
dient like pattern was restricted to the early E13 superior
colliculus and was not observed in other CNS structures.
In contrast to other PTPs, RPTPj displayed a com-
pletely overlapping expression with nestin-positive pro-
genitor cells and RC-2-positive radial glial cell processes in
the E13 superior colliculus. Recently, we showed that
RPTPj is expressed on radial processes in the embryonic
retina (Horvat-Brocker et al. 2008) and co-localizes with
nestin-positive retinal progenitor cells. Because radial glia
processes serve as cellular scaffold during CNS develop-
ment and function as guide for neuronal migration
(Newman and Reichenbach 1996; Bauch et al. 1998), the
expression on radial processes might implicate RPTPj in
the process of neuronal migration within the developing
superior colliculus. In support of this view, it has been
shown that RPTPj stimulates the migration of cancer cells
(Kim et al. 2006) and acts as cell adhesion molecule with
homophilic adhesion properties (Jiang et al. 1993; Sap
et al. 1994). Western blot analysis for RPTPj demonstrated
a complex temporal regulation of the full RPTPj protein
(164 kDa) and the proteolytic cleavage products (115-,
105- and 91 kDa). Thus, we surmise that the integral
RPTPj protein and its isoforms are functionally relevant
during mouse collicular development.
As shown for RPTPe and RPTPr, RPTPc exhibits a
predominant expression in the intermediate zone (IZ) of the
embryonic mouse superior colliculus. At E13, this layer
consists of more mature post-mitotic cells, which are gen-
erated in an inside-out sequence (Altman and Bayer 1981;
Edwardsetal.1986).Indeed,asrevealedbypreviousstudies
in the rat, RPTPc mRNA is most prominently expressed by
post-mitoticneuronsinthe superﬁciallayers ofthe postnatal
cortex (Sahin et al. 1995). However, our data additionally
indicate that the RPTPc protein is expressed by a subset of
neural progenitor and radial glia cells within the ventricular
zone. With regard to the described prominent expression of
RPTPcinpost-mitoticcells,real-timePCRandWesternBlot
analysis revealed an up-regulation of the RPTPc mRNA and
RPTPc proteolytic cleavage products (120-, 114-, 110- and
Fig. 8 Co-localization of PTP1C, PTP1D, PTP-MEG2 and PTP-
PEST proteins in RC-2-positive radial glia cells in the E13 mouse
superior colliculus. Sagittal sections through the embryonic E13
superior colliculus were double-labeled with antibodies against
intracellular PTPs and the radial glia marker RC-2. Arrowheads
indicate examples of double-labeled cells. PTP1D, PTP-MEG2 and
PTP-PEST epitopes partially co-localize with RC-2-positive radial
glia cells. In contrast, PTP1C immunoreactivity shows a less
pronounced co-localization with RC-2 positive cells in the ventricular
zone and does not co-localize with minor RC-2-positive cells in the
intermediate zone. Note that the antibodies directed at intracellular
PTPs label mainly nuclei/perikarya of collicular cells; both markers
reveal an incomplete overlapping expression pattern (merge). IZ
intermediate zone, VZ/SVZ ventricular zone/subventricular zone.
Inserts: Higher magniﬁcation of immunopositive cells (merge ﬁgures
represent co-immunoreactive cells). Scale bar 50 lm
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12380 kDa) during collicular development. Nevertheless, con-
sidering our observation that RPTPc is subject to marked
proteolytic cleavage, we suppose a diversity of functions of
RPTPc during collicular development. For example, RPTPc
is involved in the differentiation of oligodendrocytes
(Ranjan and Hudson 1996; Fraser et al. 2006) and inhibits
NGF-induced neurite outgrowth of PC12D cells (Shintani
et al. 2001).
Our analyses of RPTPe revealed a minor mRNA- and
protein-expression within the embryonic superior collicu-
lus, which was followed by a gradual up-regulation of
mRNA and protein during collicular maturation. In some
systems, RPTPe can downregulate mitogenic signaling by
inhibiting MAP-kinase activity (Wabakken et al. 2002;
Toledano-Katchalski et al. 2003) and JAK-STAT-signaling
in M1 leukemia cells (Tanuma et al. 2000, 2001, 2003).
Furthermore, RPTPe negatively regulates proliferation of
endothelial cells (Thompson et al. 2001). Based on these
studies, we assume that the faint expression of RPTPe is
required to permit proliferation of early collicular cells.
RPTPe was widely expressed with ongoing maturation,
while at early embryonic stages it was mainly conﬁned to
the superﬁcial layer of the superior colliculus. In fact,
studies of the physiological roles of RPTPe in the brain
discuss the biological signiﬁcance of this PTP in neuronal
differentiation processes (Mukouyama et al. 1997). This
assumption is in accordance with the observed minor co-
expression of RPTPe in immature, partially proliferative,
nestin- and RC-2-positive precursor/radial glia cells within
the ventricular zone.
Previous studies pointed out that several transmembrane
and cytoplasmatic isoforms of the RPTPRR gene are
known (Augustine et al. 2000a; Chirivi et al. 2004). In the
developing superior colliculus, our Western blot results
indicate the differential expression of three alternative
splicing variants (RPTPBr7 (74 kDa), RPTPPBSd (?)
(51 kDa) and RPTPPBSd (-) (47 kDa)) of the RPTPRR
gene. In addition, we identiﬁed a 155 kDa protein band,
which might represent a glycosylated form of one of the
described receptor-like isoforms. With the exception of
RPTPPBSd (?), all RPTPRR proteins were found promi-
nently expressed in early embryonic collicular stages. A
similar developmental regulation of the RPTPRR gene and
the corresponding alternatively spliced variants has been
reported in the retina (Horvat-Brocker et al. 2008), in
Purkinje cells (van den Maagdenberg et al. 1999) and
during chondrogenesis (Augustine et al. 2000a). Consid-
ering the generation and developmentally distinct regula-
tion of multiple isoforms from a single gene through
alternative splicing, it seems plausible that the identiﬁed
RPTPRR proteins regulate various biological and physio-
logical processes at different developmental time points.
Fig. 9 Co-localization of RPTPJ, RPTPj, RPTPc, RPTPe, RPTPRR
and RPTPr proteins in RC-2-positive radial glia cells in the E13
mouse superior colliculus. Sagittal sections through the embryonic
E13 superior colliculus were double-labeled with antibodies against
RPTPs and the radial glia marker RC-2. Arrowheads indicate
examples of double-labeled cells. RC-2 is restricted to radial glia
processes in the superior colliculus, and only RPTPj immunoreac-
tivity completely overlaps with radial ﬁbers (merge). RPTPJ, RPTPc,
RPTPe, RPTPRR, RPTPr immunoreactivities were mainly restricted
to the nuclei/perikarya of collicular radial glia. Nevertheless, a partial
overlap was observed for RPTPc, RPTPe, RPTPRR and RPTPr,
whereas RPTPJ positive nuclei showed no association with RC-2
positive ﬁbers. IZ intermediate zone, VZ/SVZ ventricular zone/
subventricular zone. Inserts: Higher magniﬁcation of immunopositive
cells (merge ﬁgures represent co-immunoreactive cells). Scale bar
50 lm
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123In contrast to the other RPTPs, RPTPr mRNA was
downregulated in the late postnatal stages (at P12 and at
P20), correlating well with the completion of the retino-
collicular map. On protein level, we observed a nearby
constant expression during development. In RGC axons of
Xenopus and chicken, RPTPr promotes retinal neurite
outgrowth (Burden-Gulley and Brady-Kalnay 1999; Ledig
et al. 1999; Johnson et al. 2001), growth cone guidance
(Burden-Gulley et al. 2002) and targeting of retinal axons
within the optic tectum (Rashid-Doubell et al. 2002). We
assume an analogous functional role of RPTPr in the
mouse superior colliculus. Furthermore, our results parallel
the previously described expression of RPTPr in the ven-
tricular and subventricular zones of the developing CNS
(Walton et al. 1993; Meathrel et al. 2002), where RPTPr
plays an important role in neural stem cell differentiation.
Accordingly, the expression of RPTPe in early collicular
progenitors and radial glia cells is suggestive of a func-
tional relevance of this PTP in stem cell development.
Acknowledgments We gratefully acknowledge the excellent tech-
nical assistance of Stephanie Chun, Marion Voelzkow and Sabine
Kindermann. This work was supported by the German Research
Council (DFG, SFB 509: neuronal mechanisms of vision), the
Research School of the Ruhr-University Bochum (DFG GSC98/1)
and the grant ‘‘Regulation of retinal stem cells by neural extracellular
matrix and tyrosinephosphatases’’ (DFG, FA 159/14-1).
References
Aicher B, Lerch MM, Muller T, Schilling J, Ullrich A (1997) Cellular
redistribution of protein tyrosine phosphatases LAR and
PTPsigma by inducible proteolytic processing. J Cell Biol
138:681–696
Altman J, Bayer SA (1981) Time of origin of neurons of the rat
superior colliculus in relation to other components of the visual
and visuomotor pathways. Exp Brain Res 42:424–434
Anders L, Mertins P, Lammich S, Murgia M, Hartmann D, Saftig P,
Haass C, Ullrich A (2006) Furin-, ADAM 10-, and gamma-
secretase-mediated cleavage of a receptor tyrosine phospha-
tase and regulation of beta-catenin’s transcriptional activity. Mol
Cell Biol 26:3917–3934
Augustine KA, Rossi RM, Silbiger SM, Bucay N, Duryea D, Marshall
WS, Medlock ES (2000a) Evidence that the protein tyrosine
phosphatase (PC12, Br7, Sl) gamma (-) isoform modu-
lates chondrogenic patterning and growth. Int J Dev Biol
44:361–371
Augustine KA, Silbiger SM, Bucay N, Ulias L, Boynton A, Trebasky
LD, Medlock ES (2000b) Protein tyrosine phosphatase (PC12,
Br7, S1) family: expression characterization in the adult human
and mouse. Anat Rec 258:221–234
Bard JL, Kaufman MH, Dubreuil C, Brune RM, Burger A, Baldock
RA, Davidson DR (1998) An internet-accessible database of
mouse developmental anatomy based on a systematic nomen-
clature. Mech Dev 74:111–120
Barnea G, Silvennoinen O, Shaanan B, Honegger AM, Canoll PD,
D’Eustachio P, Morse B, Levy JB, Laforgia S, Huebner K et al
(1993) Identiﬁcation of a carbonic anhydrase-like domain in the
extracellular region of RPTP gamma deﬁnes a new subfamily of
receptor tyrosine phosphatases. Mol Cell Biol 13:1497–1506
Bauch H, Stier H, Schlosshauer B (1998) Axonal versus dendritic
outgrowth is differentially affected by radial glia in discrete
layers of the retina. J Neurosci 18:1774–1785
Becher A, Drenckhahn A, Pahner I, Ahnert-Hilger G (1999a) The
synaptophysin–synaptobrevin complex is developmentally
upregulated in cultivated neurons but is absent in neuroendocrine
cells. Eur J Cell Biol 78:650–656
Becher A, Drenckhahn A, Pahner I, Margittai M, Jahn R, Ahnert-
Hilger G (1999b) The synaptophysin–synaptobrevin complex:
a hallmark of synaptic vesicle maturation. J Neurosci
19:1922–1931
Berset TA, Hoier EF, Hajnal A (2005) The C. elegans homolog of the
mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR
signaling to regulate binary cell fate decisions. Genes Dev
19:1328–1340
Bixby JL (2000) Receptor tyrosine phosphatases in axon growth and
guidance. NeuroReport 11:R5–R10
Bourdeau A, Dube N, Tremblay ML (2005) Cytoplasmic protein
tyrosine phosphatases, regulation and function: the roles of
PTP1B and TC-PTP. Curr Opin Cell Biol 17:203–209
Burden-Gulley SM, Brady-Kalnay SM (1999) PTPmu regulates N-
cadherin-dependent neurite outgrowth. J Cell Biol 144:1323–
1336
Burden-Gulley SM, Ensslen SE, Brady-Kalnay SM (2002) Protein
tyrosine phosphatase-mu differentially regulates neurite out-
growth of nasal and temporal neurons in the retina. J Neurosci
22:3615–3627
Chirivi RG, Dilaver G, van de Vorstenbosch R, Wanschers B,
Schepens J, Croes H, Fransen J, Hendriks W (2004) Character-
ization of multiple transcripts and isoforms derived from the
mouse protein tyrosine phosphatase gene Ptprr. Genes Cells
9:919–933
Cook T (2003) Cell diversity in the retina: more than meets the eye.
Bioessays 25:921–925
Davidson D, Veillette A (2001) PTP-PEST, a scaffold protein
tyrosine phosphatase, negatively regulates lymphocyte activation
by targeting a unique set of substrates. EMBO J 20:3414–3426
Davidson D, Cloutier JF, Gregorieff A, Veillette A (1997) Inhibitory
tyrosine protein kinase p50csk is associated with protein–
tyrosine phosphatase PTP-PEST in hemopoietic and non-hemo-
poietic cells. J Biol Chem 272:23455–23462
Edwards MA, Schneider GE, Caviness VS Jr (1986) Development of
the crossed retinocollicular projection in the mouse. J Comp
Neurol 248:410–421
Elson A, Leder P (1995) Protein–tyrosine phosphatase epsilon. An
isoform speciﬁcally expressed in mouse mammary tumors
initiated by v-Ha-ras OR neu. J Biol Chem 270:26116–26122
Feldheim DA, Kim YI, Bergemann AD, Frisen J, Barbacid M,
Flanagan JG (2000) Genetic analysis of ephrin-A2 and ephrin-
A5 shows their requirement in multiple aspects of retinocollic-
ular mapping. Neuron 25:563–574
Feldheim DA, Nakamoto M, Osterﬁeld M, Gale NW, DeChiara TM,
Rohatgi R, Yancopoulos GD, Flanagan JG (2004) Loss-of-
function analysis of EphA receptors in retinotectal mapping.
J Neurosci 24:2542–2550
Flanagan JG, Vanderhaeghen P (1998) The ephrins and Eph receptors
in neural development. Annu Rev Neurosci 21:309–345
Fraser L, Wysocki P, Ciereszko A, Plucienniczak G, Kotlowska M,
Kordan W, Wojtczak M, Dietrich G, Strzezek J (2006)
Application of biochemical markers for identiﬁcation of biolog-
ical properties of animal semen. Reprod Biol 6(Suppl 1):5–20
Fuchs M, Muller T, Lerch MM, Ullrich A (1996) Association of
human protein–tyrosine phosphatase kappa with members of the
armadillo family. J Biol Chem 271:16712–16719
294 Exp Brain Res (2009) 199:279–297
123Galileo DS, Gray GE, Owens GC, Majors J, Sanes JR (1990) Neurons
and glia arise from a common progenitor in chicken optic
tectum: demonstration with two retroviruses and cell type-
speciﬁc antibodies. Proc Natl Acad Sci USA 87:458–462
Garrity PA, Lee CH, Salecker I, Robertson HC, Desai CJ, Zinn K,
Zipursky SL (1999) Retinal axon target selection in Drosophila
is regulated by a receptor protein tyrosine phosphatase. Neuron
22:707–717
Garton AJ, Tonks NK (1999) Regulation of ﬁbroblast motility by
the protein tyrosine phosphatase PTP-PEST. J Biol Chem
274:3811–3818
Garton AJ, Burnham MR, Bouton AH, Tonks NK (1997) Association
of PTP-PEST with the SH3 domain of p130cas; a novel
mechanism of protein tyrosine phosphatase substrate recogni-
tion. Oncogene 15:877–885
Godement P, Salaun J, Imbert M (1984) Prenatal and postnatal
development of retinogeniculate and retinocollicular projections
in the mouse. J Comp Neurol 230:552–575
Gotz M, Huttner WB (2005) The cell biology of neurogenesis. Nat
Rev Mol Cell Biol 6:777–788
Halle M, Liu YC, Hardy S, Theberge JF, Blanchetot C, Bourdeau A,
Meng TC, Tremblay ML (2007) Caspase-3 regulates catalytic
activity and scaffolding functions of the protein tyrosine
phosphatase PEST, a novel modulator of the apoptotic response.
Mol Cell Biol 27:1172–1190
Herrera E, Brown L, Aruga J, Rachel RA, Dolen G, Mikoshiba K,
Brown S, Mason CA (2003) Zic2 patterns binocular vision by
specifying the uncrossed retinal projection. Cell 114:545–557
Horvat A, Schwaiger F, Hager G, Brocker F, Streif R, Knyazev P,
Ullrich A, Kreutzberg GW (2001) A novel role for protein
tyrosine phosphatase shp1 in controlling glial activation in the
normal and injured nervous system. J Neurosci 21:865–874
Horvat-Brocker A, Reinhard J, Illes S, Paech T, Zoidl G, Harroch S,
Distler C, Knyazev P, Ullrich A, Faissner A (2008) Receptor
protein tyrosine phosphatases are expressed by cycling retinal
progenitor cells and involved in neuronal development of mouse
retina. Neuroscience 152:618–645
Ibarra-Sanchez MJ, Simoncic PD, Nestel FR, Duplay P, Lapp WS,
Tremblay ML (2000) The T-cell protein tyrosine phosphatase.
Semin Immunol 12:379–386
Jallal B, Mossie K, Vasiloudis G, Knyazev P, Zachwieja J,
Clairvoyant F, Schilling J, Ullrich A (1997) The receptor-like
protein–tyrosine phosphatase DEP-1 is constitutively associated
with a 64-kDa protein serine/threonine kinase. J Biol Chem
272:12158–12163
Jena B, Webster P, Geibel JP, Van den Pol AN, Sritharan KC (1997)
Localization of SH-PTP1 to synaptic vesicles: a possible role in
neurotransmission. Cell Biol Int 21:469–476
Jiang YP, Wang H, D’Eustachio P, Musacchio JM, Schlessinger J,
Sap J (1993) Cloning and characterization of R-PTP-kappa, a
new member of the receptor protein tyrosine phosphatase family
with a proteolytically cleaved cellular adhesion molecule-like
extracellular region. Mol Cell Biol 13:2942–2951
Johnson KG, McKinnell IW, Stoker AW, Holt CE (2001) Receptor
protein tyrosine phosphatases regulate retinal ganglion cell axon
outgrowth in the developing Xenopus visual system. J Neurobiol
49:99–117
Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S
(1996) The protein tyrosine phosphatase DEP-1 is induced
during differentiation and inhibits growth of breast cancer cells.
Cancer Res 56:4236–4243
Kim YS, Kang HY, Kim JY, Oh S, Kim CH, Ryu CJ, Miyoshi E,
Taniguchi N, Ko JH (2006) Identiﬁcation of target proteins of
N-acetylglucosaminyl transferase V in human colon cancer and
implications of protein tyrosine phosphatase kappa in enhanced
cancer cell migration. Proteomics 6:1187–1191
Kuramochi S, Matsuda S, Matsuda Y, Saitoh T, Ohsugi M,
Yamamoto T (1996) Molecular cloning and characterization of
Byp, a murine receptor-type tyrosine phosphatase similar to
human DEP-1. FEBS Lett 378:7–14
Lam MH, Michell BJ, Fodero-Tavoletti MT, Kemp BE, Tonks NK,
Tiganis T (2001) Cellular stress regulates the nucleocytoplasmic
distribution of the protein–tyrosine phosphatase TCPTP. J Biol
Chem 276:37700–37707
LammersR,BossenmaierB,CoolDE,TonksNK,SchlessingerJ,Fischer
EH, Ullrich A (1993) Differential activities of protein tyrosine
phosphatases in intact cells. J Biol Chem 268:22456–22462
Ledig MM, Haj F, Bixby JL, Stoker AW, Mueller BK (1999) The
receptor tyrosine phosphatase CRYPalpha promotes intraretinal
axon growth. J Cell Biol 147:375–388
Li R, Gaits F, Ragab A, Ragab-Thomas JM, Chap H (1994)
Translocation of an SH2-containing protein tyrosine phosphatase
(SH-PTP1) to the cytoskeleton of thrombin-activated platelets.
FEBS Lett 343(1):89–93
Lo FS, Mize RR (1999) Retinal input induces three ﬁring patterns in
neurons of the superﬁcial superior colliculus of neonatal rats.
J Neurophysiol 81:954–958
Massa PT, Wu C, Fecenko-Tacka K (2004) Dysmyelination and
reduced myelin basic protein gene expression by oligodendro-
cytes of SHP-1-deﬁcient mice. J Neurosci Res 77:15–25
Matozaki T, Suzuki T, Uchida T, Inazawa J, Ariyama T, Matsuda K,
Horita K, Noguchi H, Mizuno H, Sakamoto C et al (1994)
Molecular cloning of a human transmembrane-type protein
tyrosine phosphatase and its expression in gastrointestinal
cancers. J Biol Chem 269(3):2075–2081
Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J
(2005) Negative regulation of EGFR signalling through integrin-
alpha1beta1-mediated activation of protein tyrosine phosphatase
TCPTP. Nat Cell Biol 7:78–85
Meathrel K, Adamek T, Batt J, Rotin D, Doering LC (2002) Protein
tyrosine phosphatase sigma-deﬁcient mice show aberrant cyto-
architecture and structural abnormalities in the central nervous
system. J Neurosci Res 70:24–35
Miao W, Luo Z, Kitsis RN, Walsh K (2000) Intracoronary,
adenovirus-mediated Akt gene transfer in heart limits infarct
size following ischemia-reperfusion injury in vivo. J Mol Cell
Cardiol 32(12):2397–2402
Moller NP, Moller KB, Lammers R, Kharitonenkov A, Hoppe E,
Wiberg FC, Sures I, Ullrich A (1995) Selective down-regulation
of the insulin receptor signal by protein-tyrosine phosphatases
alpha and epsilon. J Biol Chem 270:23126–23131
Mukouyama Y, Kuroyanagi H, Shirasawa T, Tomoda T, Saffen D,
Oishi M, Watanabe T (1997) Induction of protein tyrosine
phosphatase epsilon transcripts during NGF-induced neuronal
differentiation of PC12D cells and during the development of the
cerebellum. Brain Res Mol Brain Res 50:230–236
Newman E, Reichenbach A (1996) The Muller cell: a functional
element of the retina. Trends Neurosci 19:307–312
Newsome TP, Asling B, Dickson BJ (2000) Analysis of Drosophila
photoreceptor axon guidance in eye-speciﬁc mosaics. Develop-
ment 127:851–860
Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M (1994) Role
of SH-PTP2, a protein-tyrosine phosphatase with Src homology
2 domains, in insulin-stimulated Ras activation. Mol Cell Biol
14:6674–6682
O’Leary DD, McLaughlin T (2005) Mechanisms of retinotopic map
development: Ephs, ephrins, and spontaneous correlated retinal
activity. Prog Brain Res 147:43–65
Ogata M, Sawada M, Fujino Y, Hamaoka T (1995) cDNA cloning
and characterization of a novel receptor-type protein tyrosine
phosphatase expressed predominantly in the brain. J Biol Chem
270:2337–2343
Exp Brain Res (2009) 199:279–297 295
123Pathre P, Arregui C, Wampler T, Kue I, Leung TC, Lilien J, Balsamo J
(2001) PTP1B regulates neurite extension mediated by cell–cell
and cell–matrix adhesion molecules. J Neurosci Res 63:143–150
Persson C, Savenhed C, Bourdeau A, Tremblay ML, Markova B,
Bohmer FD, Haj FG, Neel BG, Elson A, Heldin CH, Ronnstrand
L, Ostman A, Hellberg C (2004) Site-selective regulation of
platelet-derived growth factor beta receptor tyrosine phosphor-
ylation by T-cell protein tyrosine phosphatase. Mol Cell Biol
24:2190–2201
Pfafﬂ MW, Horgan GW, Dempﬂe L (2002) Relative expression
software tool (REST) for group-wise comparison and statistical
analysis of relative expression results in real-time PCR. Nucl
Acids Res 30:e36
Poliakov A, Cotrina M, Wilkinson DG (2004) Diverse roles of eph
receptors and ephrins in the regulation of cell migration and
tissue assembly. Dev Cell 7:465–480
Ranjan M, Hudson LD (1996) Regulation of tyrosine phosphorylation
and protein tyrosine phosphatases during oligodendrocyte dif-
ferentiation. Mol Cell Neurosci 7:404–418
Rashid-Doubell F, McKinnell I, Aricescu AR, Sajnani G, Stoker A
(2002) Chick PTPsigma regulates the targeting of retinal axons
within the optic tectum. J Neurosci 22:5024–5033
Ray A, Zoidl G, Weickert S, Wahle P, Dermietzel R (2005) Site-
speciﬁc and developmental expression of pannexin1 in the
mouse nervous system. Eur J Neurosci 21:3277–3290
Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C,
Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot
PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse
H, Paces V, van Zandwijk N, van Ommen GJ, Demant P (2002)
Ptprj is a candidate for the mouse colon-cancer susceptibility
locus Scc1 and is frequently deleted in human cancers. Nat
Genet 31:295–300
Sahin M, Dowling JJ, Hockﬁeld S (1995) Seven protein tyrosine
phosphatases are differentially expressed in the developing rat
brain. J Comp Neurol 351:617–631
Sap J, Jiang YP, Friedlander D, Grumet M, Schlessinger J (1994)
Receptor tyrosine phosphatase R-PTP-kappa mediates homo-
philic binding. Mol Cell Biol 14:1–9
Sharma E, Lombroso PJ (1995) A neuronal protein tyrosine
phosphatase induced by nerve growth factor. J Biol Chem
270:49–53
Shen Y, Schneider G, Cloutier JF, Veillette A, Schaller MD (1998)
Direct association of protein–tyrosine phosphatase PTP-PEST
with paxillin. J Biol Chem 273:6474–6481
Shintani Y, Marunaka Y (1996) Regulation of single Cl- channel
conductance by insulin and tyrosine phosphatase. Biochem
Biophys Res Commun 218:142–147
Shintani T, Maeda N, Noda M (2001) Receptor-like protein tyrosine
phosphatase gamma (RPTPgamma), but not PTPzeta/RPTPbeta,
inhibits nerve-growth-factor-induced neurite outgrowth in
PC12D cells. Dev Neurosci 23:55–69
Simoncic PD, Bourdeau A, Lee-Loy A, Rohrschneider LR, Tremblay
ML, Stanley ER, McGlade CJ (2006) T-cell protein tyrosine
phosphatase (Tcptp) is a negative regulator of colony-stimulating
factor 1 signaling and macrophage differentiation. Mol Cell Biol
26:4149–4160
Sirois J, Cote JF, Charest A, Uetani N, Bourdeau A, Duncan SA,
Daniels E, Tremblay ML (2006) Essential function of PTP-PEST
during mouse embryonic vascularization, mesenchyme forma-
tion, neurogenesis and early liver development. Mech Dev
123:869–880
Stein-Gerlach M, Kharitonenkov A, Vogel W, Ali S, Ullrich A (1995)
Protein-tyrosine phosphatase 1D modulates its own state of
tyrosine phosphorylation. J Biol Chem 270:24635–24637
Stoker AW (2001) Receptor tyrosine phosphatases in axon growth
and guidance. Curr Opin Neurobiol 11:95–102
Tanuma N, Nakamura K, Shima H, Kikuchi K (2000) Protein-tyrosine
phosphatase PTPepsilon C inhibits Jak-STAT signaling and
differentiation induced by interleukin-6 and leukemia inhibitory
factor in M1 leukemia cells. J Biol Chem 275:28216–28221
Tanuma N, Shima H, Nakamura K, Kikuchi K (2001) Protein tyrosine
phosphatase epsilonC selectively inhibits interleukin-6- and
interleukin- 10-induced JAK-STAT signaling. Blood
98:3030–3034
Tanuma N, Shima H, Shimada S, Kikuchi K (2003) Reduced
tumorigenicity of murine leukemia cells expressing protein-
tyrosine phosphatase, PTPepsilon C. Oncogene 22:1758–1762
Thanos S, Mey J (2001) Development of the visual system of the
chick II. Mechanisms of axonal guidance. Brain Res Brain Res
Rev 35:205–245
Thompson LJ, Jiang J, Madamanchi N, Runge MS, Patterson C
(2001) PTP-epsilon, a tyrosine phosphatase expressed in endo-
thelium, negatively regulates endothelial cell proliferation. Am J
Physiol Heart Circ Physiol 281:H396–H403
Tiganis T, Flint AJ, Adam SA, Tonks NK (1997) Association of the
T-cell protein tyrosine phosphatase with nuclear import factor
p97. J Biol Chem 272:21548–21557
Tiganis T, Bennett AM, Ravichandran KS, Tonks NK (1998)
Epidermal growth factor receptor and the adaptor protein
p52Shc are speciﬁc substrates of T-cell protein tyrosine phos-
phatase. Mol Cell Biol 18:1622–1634
Tiganis T, Kemp BE, Tonks NK (1999) The protein–tyrosine
phosphatase TCPTP regulates epidermal growth factor recep-
tor-mediated and phosphatidylinositol 3-kinase-dependent sig-
naling. J Biol Chem 274:27768–27775
Toledano-Katchalski H, Kraut J, Sines T, Granot-Attas S, Shohat G,
Gil-Henn H, Yung Y, Elson A (2003) Protein tyrosine
phosphatase epsilon inhibits signaling by mitogen-activated
protein kinases. Mol Cancer Res 1:541–550
Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E,
Ullrich A, Bohmer FD (1995) Association of SH2 domain
protein tyrosine phosphatases with the epidermal growth factor
receptor in human tumor cells. Phosphatidic acid acti-
vates receptor dephosphorylation by PTP1C. J Biol Chem
270:21277–21284
Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P,
Baldassarre G, Santoro M, Viglietto G, Fusco A (2000) Rat
protein tyrosine phosphatase eta suppresses the neoplastic
phenotype of retrovirally transformed thyroid cells through the
stabilization of p27(Kip1). Mol Cell Biol 20:9236–9246
van den Maagdenberg AM, Schepens JT, Schepens MT, Merkx GF,
Darroudi F, Wieringa B, Geurts van Kessel A, Hendriks WJ
(1999) Assignment1 of the PTP-SL/PTPBR7 gene (Ptprr/
PTPRR) to mouse chromosome region 8A2 by in situ hybrid-
ization. Cytogenet Cell Genet 84:243–244
van Niekerk CC, Poels LG (1999) Reduced expression of protein
tyrosine phosphatase gamma in lung and ovarian tumors. Cancer
Lett 137:61–73
Wabakken T, Hauge H, Finne EF, Wiedlocha A, Aasheim H (2002)
Expression of human protein tyrosine phosphatase epsilon in
leucocytes: a potential ERK pathway-regulating phosphatase.
Scand J Immunol 56:195–203
Walton KM, Martell KJ, Kwak SP, Dixon JE, Largent BL (1993) A
novel receptor-type protein tyrosine phosphatase is expressed
during neurogenesis in the olfactory neuroepithelium. Neuron
11:387–400
Wang Y, Vachon E, Zhang J, Cherepanov V, Kruger J, Li J, Saito K,
Shannon P, Bottini N, Huynh H, Ni H, Yang H, McKerlie C,
Quaggin S, Zhao ZJ, Marsden PA, Mustelin T, Siminovitch KA,
Downey GP (2005) Tyrosine phosphatase MEG2 modulates
murine development and platelet and lymphocyte activation
through secretory vesicle function. J Exp Med 202:1587–1597
296 Exp Brain Res (2009) 199:279–297
123Wishcamper C, Cofﬁn JD, Lurie DI (2001) Lack of the protein
tyrosine phosphatase SHP-1 results in decreased numbers of glia
within the motheaten (me/me) mouse brain. J Comp Neurol
441:118–133
Xu MJ, Sui X, Zhao R, Dai C, Krantz SB, Zhao ZJ (2003) PTP-
MEG2 is activated in polycythemia vera erythroid progenitor
cells and is required for growth and expansion of erythroid cells.
Blood 102:4354–4360
Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo
J, Thompson JA, Schraven BL, Philips MR, Neel BG (2004)
Shp2 regulates SRC family kinase activity and Ras/Erk activa-
tion by controlling Csk recruitment. Mol Cell 13:341–355
Exp Brain Res (2009) 199:279–297 297
123